ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 172

Transcript Profiling Of Kidney Biopsies From Chinese Patients With Lupus Nephritis Suggests a Prevalence Of Infiltrating CD8+ T Cells, Monocytes/Macrophages, and B Cells In ISN/RPS Class IV Disease

Zheng Liu1, Chris Morehouse1, Xinfang Huang2, Philip Brohawn1, Nan Shen3, Gabor G. Illei4, Yihong Yao1 and Brandon W. Higgs1, 1Translational Sciences, MedImmune, LLC, Gaithersburg, MD, 2Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, 3Division of Rheumatology & the Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children’s Hospital Medical Center, cincinnati, OH, 4Clinical Development, MedImmune, LLC, Gaithersburg, MD

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: B cells, Gene Expression, lupus nephritis and macrophages, T cells

  • Tweet
  • Email
  • Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Transcript profiling of kidney biopsies from Chinese patients with lupus nephritis suggests a prevalence of infiltrating CD8+ T cells, monocytes/macrophages, and B cells in ISN/RPS class IV disease

Background/Purpose: Lupus nephritis (LN) affects ~60% of patients with systemic lupus erythematosus (SLE).  The International Society of Nephrology and the Renal Pathology Services (ISN/RPS) classification system categorizes LN into 6 main classes based on the underlying renal pathology. Among these, Classes I and II rarely require immunosuppressive treatment and Class-VI is associated with irreversible glomerulosclerosis.  Class-IV (diffuse proliferative nephritis) is the most severe form with the largest proportion of all diagnosed cases (~40%) followed by Class-III (focal proliferative nephritis), representing ~25% of all diagnosed cases. These classes have similar histopathological and clinical characteristics while Class-V (membranous nephritis) representing ~10% of LN cases is different both in its clinical course and histological appearance.  We examined kidney biopsies from a group of ISN/RPS Class III, IV, and V LN subjects to evaluate molecular differences between these classes.

Methods: Kidney biopsies were procured from 6 healthy donor (HD) and 25 LN (8 Class-III, 6 Class-IV, and 11 Class-V) Chinese subjects. The Affymetrix U133+ array was used to transcript profile specimens.  Fold changes were calculated for each LN subject relative to the average HD expression.  Previously defined cell type-specific gene signatures were identified to be differential between ISN/RPS classes.

Results: Several gene signatures were significantly over-expressed (p<0.05) in Class-IV subjects relative to both Class-III and -V subjects.  These included: a chemokine, MHC class I, monocyte, macrophage, and CD8+ T cell gene signatures.  An immunoglobulin (Ig) signature was also significantly over-expressed in Class-IV subjects compared to Class-V subjects, but not Class-III subjects.  The following gene signatures did not significantly differ between the three classes: neutrophil, CD4+ T cell, and type I IFN. 

 

Conclusion: Transcript profiling was used to correlate the molecular differences between LN disease classifications and cell infiltrate prevalence. In addition to pathways upregulated in all three forms of LN, we identified cell type-specific signatures which were over-expressed in Class-IV. The increased CD-8+ signature suggests that CD8+ effector T cell infiltration may correlate with more active disease status. Monocytes/macrophages are also more prevalent in this more active disease class, suggesting an increase in infiltration from damage caused by these CD8+ T effector cells, which may also lead to an increase in Ig products.

Figure 1. Distribution of A) macrophage, B) CD8+ T cell, and C) Ig gene signatures for LN patients with Class-III, -IV, or -V disease.

 


Disclosure:

Z. Liu,

MedImmune LLC,

3,

AstraZeneca,

1;

C. Morehouse,

Astra Zeneca,

1;

X. Huang,
None;

P. Brohawn,

MedImmune LLC,

3,

Astra Zeneca,

1;

N. Shen,

MedImmune,

5;

G. G. Illei,

AstraZeneca,

1,

MedImmune,

3;

Y. Yao,
None;

B. W. Higgs,

MedImmune LLC,

3,

AstraZeneca,

1.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcript-profiling-of-kidney-biopsies-from-chinese-patients-with-lupus-nephritis-suggests-a-prevalence-of-infiltrating-cd8-t-cells-monocytesmacrophages-and-b-cells-in-isnrps-class-iv-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology